Dyne therapeutics inc
WebLead Portfolio Analyst, Portfolio Management (Oncology) TESARO, Inc. (Now a Subsidiary of GlaxoSmithKline (GSK)) Jul 2013 - Nov 20152 years 5 months. Newly-created … WebDyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.The company's therapies deliver nucleic acids and other molecules to skeletal, …
Dyne therapeutics inc
Did you know?
WebApr 11, 2024 · Dyne Therapeutics, Inc, a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as … WebMar 14, 2024 · 天眼查为您提供Dyne Therapeutics Inc.的企业信息查询服务，查询Dyne Therapeutics Inc.工商注册信息、公司电话、公司地址、公司邮箱网址、公司经营风险、公司发展状况、公司财务状况、公司股东法人高管、商标、融资、专利、法律诉讼等Dyne Therapeutics Inc.企业信用信息，想了解Dyne Therapeutics Inc.怎么样，就 ...
WebSep 13, 2024 · Summary. Dyne Therapeutics had filed proposed terms for a $175 million U.S. IPO. The firm is advancing treatments for various muscle diseases. DYN has yet to enter Phase 1 safety trials, so the ... WebInteldyne Salaries trends. 68 salaries for 5 jobs at Inteldyne in Sterling, VA. Salaries posted anonymously by Inteldyne employees in Sterling, VA.
WebMar 23, 2024 · About Dyne Therapeutics. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome … WebApr 11, 2024 · Dyne Therapeutics, Inc, a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven …
WebApr 5, 2024 · Dyne Therapeutics Inc's score of 87 means it scores higher than 87% of stocks in the industry. Dyne Therapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 40 out of the 148 industries. DYN has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on …
WebApr 11, 2024 · Dyne Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.63 on 09/12/22, with the lowest value was $4.30 for the same time period, recorded on 06/02/22. Top 5 EV Tech Stocks to Buy for 2024 grass for fenceWebCompany profile page for Dyne Therapeutics Inc including stock price, company news, press releases, executives, board members, and contact information grass for flower arrangementsWebJan 8, 2024 · Patent number: 11518816. Abstract: Aspects of the disclosure relate to complexes comprising a muscle-targeting agent covalently linked to a molecular payload. In some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surface receptor on muscle cells. In some embodiments, the molecular payload inhibits ... grass for golf coursesWebMar 20, 2024 · positioned for growth. Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people … grass for ground coverWebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of … grass for full shadeWebMar 14, 2024 · 天眼查为您提供Dyne Therapeutics Inc.的企业信息查询服务，查询Dyne Therapeutics Inc.工商注册信息、公司电话、公司地址、公司邮箱网址、公司经营风险、 … grass for full shade areasWebMar 23, 2024 · Dyne Therapeutics sets IPO terms, to offer 10.3 million shares priced at $16 to $18 each. Sep. 10, 2024 at 7:12 a.m. ET by Ciara Linnane. chittleford farm